04.25.24 -- Reducing The Disease Burden Of AML With Vor Bio's Dr. Robert Ang

Companies aiming to accelerate biomanufacturing operations and use resources efficiently need access to technologies that can safely and efficiently complete their workflow from idea to injection.

Learn in detail about Annex 16, the responsibilities of marketing authorization holders (MAHs), and a practical way for MAHs to implement their responsibilities with their contract manufacturers.

Get a recap of what industry experts had to say about single-arm oncology registrational studies, success stories, and valuable lessons learned.

For vector-based therapeutics, testing for replication-competent viruses is crucial but prolongs release times. Which tools can help developers and manufacturers be confident in their CGT products?

Explore how the UFMini single-use centrifuge significantly reduces filtration needs and drastically enhances the amount of viral titer collected when compared to conventional methods.

Elevate your viral vector production to commercial scale by choosing the optimal production system paired with the right single-use bioreactor combination.